ACADIA Pharmaceuticals In... (ACAD)
NASDAQ: ACAD
· Real-Time Price · USD
22.12
0.41 (1.89%)
At close: Jun 16, 2025, 3:59 PM
21.34
-3.53%
After-hours: Jun 16, 2025, 07:49 PM EDT
1.89% (1D)
| Bid | 21.34 |
| Market Cap | 3.7B |
| Revenue (ttm) | 996.28M |
| Net Income (ttm) | 228.88M |
| EPS (ttm) | 1.37 |
| PE Ratio (ttm) | 16.15 |
| Forward PE | 25.59 |
| Analyst | Buy |
| Ask | 22.18 |
| Volume | 737,899 |
| Avg. Volume (20D) | 2,064,628 |
| Open | 21.73 |
| Previous Close | 21.71 |
| Day's Range | 21.38 - 22.16 |
| 52-Week Range | 13.40 - 25.23 |
| Beta | 0.65 |
About ACAD
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ACAD
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ACAD stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+26.48%
ACADIA Pharmaceuticals shares are trading higher a...
Unlock content with
Pro Subscription
1 month ago
+14.31%
ACADIA Pharmaceuticals shares are trading higher after the company reported better-than-expected Q1 financial results.
1 month ago · seekingalpha.com
Acadia Pharmaceuticals: Another Legal Win, ACP-101 Readout PreviewAcadia Pharmaceuticals secured another court win on Nuplazid that solidifies its IP position and long-term exclusivity. The commercial business' performance remains slightly underwhelming but there ar...